Gil Blum
Stock Analyst at Needham
(1.95)
# 2,806
Out of 4,814 analysts
370
Total ratings
31.27%
Success rate
-9.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Reiterates: Buy | $29 | $10.22 | +183.76% | 15 | Apr 11, 2025 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $6 | $1.25 | +380.00% | 26 | Apr 10, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.43 | +599.30% | 27 | Apr 10, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $84 | $37.76 | +122.46% | 20 | Apr 9, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $3.10 | +190.32% | 3 | Apr 9, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $23 | $2.23 | +933.71% | 5 | Apr 8, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $61.99 | +69.38% | 23 | Dec 10, 2024 | |
| GBIO Generation Bio Co. | Reiterates: Buy | $8 | $0.39 | +1,945.51% | 16 | Apr 10, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $71 | $28.54 | +148.77% | 14 | Apr 10, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $28 → $27 | $9.32 | +189.70% | 23 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $6.33 | +563.51% | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.31 | +203.69% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $10.40 | +294.23% | 14 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.72 | +539.53% | 16 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.44 | +525.00% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $5.50 | +100.00% | 22 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.85 | +370.59% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $202 → $183 | $53.79 | +240.21% | 30 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.77 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.27 | +295.26% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.12 | - | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.83 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.34 | +1,083.43% | 9 | Aug 2, 2024 |
Celcuity
Apr 11, 2025
Reiterates: Buy
Price Target: $29
Current: $10.22
Upside: +183.76%
Taysha Gene Therapies
Apr 10, 2025
Reiterates: Buy
Price Target: $6
Current: $1.25
Upside: +380.00%
Autolus Therapeutics
Apr 10, 2025
Reiterates: Buy
Price Target: $10
Current: $1.43
Upside: +599.30%
CRISPR Therapeutics AG
Apr 9, 2025
Reiterates: Buy
Price Target: $84
Current: $37.76
Upside: +122.46%
Absci
Apr 9, 2025
Reiterates: Buy
Price Target: $9
Current: $3.10
Upside: +190.32%
Artiva Biotherapeutics
Apr 8, 2025
Reiterates: Buy
Price Target: $23
Current: $2.23
Upside: +933.71%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $61.99
Upside: +69.38%
Generation Bio Co.
Apr 10, 2025
Reiterates: Buy
Price Target: $8
Current: $0.39
Upside: +1,945.51%
Immunocore Holdings
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $28.54
Upside: +148.77%
Nurix Therapeutics
Apr 9, 2025
Maintains: Buy
Price Target: $28 → $27
Current: $9.32
Upside: +189.70%
Apr 9, 2025
Reiterates: Buy
Price Target: $42
Current: $6.33
Upside: +563.51%
Apr 9, 2025
Reiterates: Buy
Price Target: $7
Current: $2.31
Upside: +203.69%
Apr 9, 2025
Reiterates: Buy
Price Target: $41
Current: $10.40
Upside: +294.23%
Apr 9, 2025
Reiterates: Buy
Price Target: $11
Current: $1.72
Upside: +539.53%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.44
Upside: +525.00%
Apr 8, 2025
Reiterates: Buy
Price Target: $11
Current: $5.50
Upside: +100.00%
Apr 4, 2025
Reiterates: Buy
Price Target: $4
Current: $0.85
Upside: +370.59%
Apr 3, 2025
Maintains: Buy
Price Target: $202 → $183
Current: $53.79
Upside: +240.21%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.77
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.27
Upside: +295.26%
Mar 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.12
Upside: -
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.83
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.34
Upside: +1,083.43%